iiib
Entity, reached from Hormuz.
- Evidence
- 25 documents · 7 separate publishers
- Standing
- Added automatically from coverage
- Time
- first seen 25 Aug 2026, last seen 9 Oct 2026
- Measured
- 0% of mentions say something specific about it; the rest only name it
- As of
- 10 Oct 2026
Where this comes from
- Clinical Trials Arena · 2026-10-07 · ViiV Healthcare’s Cabenuva beats daily oral ART in Phase IIIb trial (opens the source in a new tab)
- AllSci News · 2026-10-07 · Cabenuva shows potential to move beyond suppressed HIV patients after Phase IIIb win (opens the source in a new tab)
- AllSci News · 2026-10-01 · Lilly's Ebglyss wins Phase IIIb trial in hand and foot atopic dermatitis, seeks label expansion (opens the source in a new tab)
- Clinical Trials Arena · 2026-09-21 · Otsuka reports expanded Phase IIIb results for Simtriyo in adult ADHD (opens the source in a new tab)
- The ASCO Post · 2026-09-14 · Perioperative Atezolizumab Plus Chemotherapy Improves Outcomes in Resectable Stage II–IIIB NSCLC (opens the source in a new tab)
- The ASCO Post · 2026-09-14 · General Email (opens the source in a new tab)
What is claimed about it
Situations it is named in
Who it moves with
- co-mentioned with lung cancer (17 documents)seen together
- co-mentioned with iaslc (12 documents)seen together
- co-mentioned with wclc (12 documents)seen together
- co-mentioned with egfr (12 documents)seen together
- co-mentioned with cancer center (11 documents)seen together
- co-mentioned with egfr-mutated (9 documents)seen together
- co-mentioned with her2 (9 documents)seen together
- co-mentioned with her2-mutant (8 documents)seen together
- co-mentioned with dana-farber cancer institute (8 documents)seen together
- co-mentioned with iiia (8 documents)seen together